A previously reported patient with analbuminemia was re-investigated after 41/2 years, at age 6. The serum albumin concentration was 150 mg/L by radioimmunoassay. Most of the observed increase in total plasma protein over the 41/2 years was attributable to gamma-globulin. Concentrations of total and high-density lipoprotein cholesterol were increased; the esterified:free ratio and the lecithincholesterol acyltransferase activity were both normal. Albumin is apparently not essential for binding of lysolecithin generated by the acyltransferase-catalyzed reaction. The binding of bromphenol blue suggested that analbuminemic serum has about 25% of normal binding capacity for bilirubin (more than expected in a patient with analbuminemia), which may explain why newborns with this disorder do not develop kernicterus. Binding by the patient's plasma of diazepam (1020 mg/L) and warfarin (1040 mg/L), which bind primarily to albumin, as well as of propranolol (1.05 g/L), which binds primarily to a1-acid glycoprotein, was also studied. The proportions of free diazepam (14.4%) and warfarin (4.8%) were about 10-fold normal. In contrast, the proportion of propranolol in the free form was decreased (4.5%). Evidently, other plasma proteins are partly compensating for the deficiency of albumin.
first described by Bennhold et al. in 1954 (1) . Only 13 other patients with this condition, including our own, have been described so far (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Follow-up of these patients is desirable because this "experiment of nature" can help us to understand the physiological role of albumin and the compensatory mechanism operating in its absence. Rather remarkably, the individuals deficient in albumin show only minor clinical and biochemical abnormalities. A parallel to the human condition, an analbuminemic strain of rats, was recently described (14) . These animals grow, reproduce, and have a life span identical to their normal litter mates. While the loss of the plasma oncotic pressure, to which albumin ordinarily contributes about 80%, can be compensated for by an increase in other small protein molecules and a decrease in blood pressure, little is known about compensation for the binding and transport functions of albumin.
We investigated the changes in plasma proteins with development of a previously described child with analbumi- activity. To assess the bilirubin-bmnding capacity of the patient's plasma, we used bromphenol blue, addressing ourselves to the question of perinatal jaundice and its treatment in this particular patient. The capacity of the patient's plasma to bind drugs ordinarily bound by albumin and a,-acid glycoprotein was also studied.
Materials and Methods
This child was the subject of a previous report at age 1 Drug-binding studies.
The plasma protein binding of diazepam, warfarin, and propranolol was studied in duplicate at therapeutic total drug concentrations by an equilibrium dialysis method described previously (19) . These drugs were chosen as representative of classes of drugs that bind to the tryptophan-bmnding site on human serum albumin (20) (diazepam), to the acidic drug site on albumin (21) (warfarin), and to both a1-acid glycoprotein and lipoproteins
Lipid studies. Plasma total and free cholesterol and triglycerides were determined as described previously
(23).
High-density lipoprotemn (HDL) cholesterol was determined by manganese chloride and heparin precipitation (24) . LCAT activity was determined by the Stokke-Norum method (25) , including different amounts of albumin in the assay (final albumin concentration ranged from 10 to 50 gIL). Human serum albumin (Connaught Laboratories, Toronto, Ontario) was used in these studies. Lipoprotein electrophoresis on 'By radial immunodiffusion. #{176} By radiolmmunoassay.
agarose and on polyacrylamide gel was performed by previously described methods (23) .
Results
Plasma proteins. Table 1 summarizes the findings at age 31 days, l/2, 3'/2, and 6'/2 years of age. Only trace amounts of albumin were found after immunoelectrophoresis; its concentration by radial immunodiffusion was unchanged at approximately 100 mgIL over the 6'/2-year period. Albumin concentration at 6'/2 years of age was 150 mg/L by radioimmunoassay. Electrophoresis showed increases in all a1-, a2-, 3-, and y-globulins, the values for immunoglobulins being higher than the normal range for his age group. Increases in the concentration of numerous proteins (in comparison with a control) were observed and are summarized in Table 2 (Figure 2 ). Despite the almost complete absence of albumin in our patient's serum there was still a shift in the BPB spectrum, resulting in differences of absorbance that were approximately one-fourth of normal (one-half of the change with nephrotic serum). If albumin were the only protein binding BPB, the analbuminetnic serum's binding capacity would be that of about 12 g of albumin per liter.
Drug-binding studies.
Results of the drug-binding studies are shown in Table 4 , along with typical reported values for proportions of unbound drugs in normal individuals. The unbound portion of diazepam was 14.37% of the total, 11.5-fold higher than normals. Free warfarin was also increased, (Hp 2-2) . The significance of this finding is not known but is apparently unrelated to the analbuminemia, the relatives of Weinstock's patient having had normal albumin but low haptoglobin concentrations.
The increase in the synthesis of proteins of low molecular mass compensates, by approximately 50%, for the loss of the colloid osmotic pressure that results from the absence of albumin. As previously pointed out (10) , this fact, together with low blood pressure, partly explains the lack of significant edema in most analbuminemic individuals.
The catabolism of albumin (10) and other plasma proteins might also be influenced by their concentration or by oncotic pressure of plasma. Thus both increased protein synthesis and decreased catabolism may contribute to "compensatory" plasma protein changes in analbuminemia. High-resolution protein electrophoresis and analytical ultracentrifugation were used to search for possible unusual proteins. No additional or unusual bands were observed on agarose gel electrophoresis (Figure 1) . In contrast to Keller et al. (6) , who reported the presence of small amounts of 0.7, 2.1, and 3.3S protein fragments on several occasions in the serum of their patient, we could not demonstrate the presence of low-molecular-mass fragments. The pattern we obtained on analytical ultracentrifugation was very similar to that found in a patient with nephrotic syndrome and severe hypoalbuminemia (unpublished observation).
A previously reported inverse relationship between concentrations of albumin and serum cholesterol (26) was presumed to be related to the serum colloid osmotic pressure.
These findings are supported by the studies in analbuminemic rats and in perfused liver from nephrotic rats. Although in analbuminemic rats both the plasma cholesterol and triglycerides are increased (14) , only the serum cholesterol concentration is high in most analbuminemic individuals. Both increased synthesis and decreased catabolism may contribute to the increased concentration of the low-density lipoprotein (LDL) and therefore to the hypercholesterolemia in our patient. The finding of a normal ratio of free/esterified cholesterol and a normal value for LCAT activity is of interest.
Obviously albumin is not necessary for binding lysolecithin generated by the LCAT reaction.
Some analbuminemic individuals may be at risk for cardiovascular disease because of the hypercholesterolemia. A large proportion of newborns do not exceed that concentration of bilirubin, and therefore it is not too surprising that kernicterus has not been reported in a patient with analbuminemia.
We were unable to demonstrate the presence of alternative BPB and bilirubin-binding proteins, using an electrophoretic technique similar to Goulle et al. (13) . Our results tended to support their findings that bilirubin apparently exists in unbound form when present at greater than 10 mgIL (results not shown). We cannot, however, completely exclude the possibility of a loose association between bilirubin and some of the other patient's plasma proteins (or lipoproteins?). In normal pharmacological situations albumin is the major binding protein of both diazepam (28) and warfarin (29) . Accordingly, the unbound fraction of these representative drugs was greatly increased in the analbuminemic plasma. The proportion of drug that was unbound was approximately that predicted from an albumin concentration one-tenth that of normal (35-55 g/L). This indicates that plasma proteins other than albumin are serving a significant transport role, and if this same kind of adjustment occurs for endogenous ligands as well, may be one contributor to the lack of clinical sequelae in this disorder. The 11.5-and 8.5-fold increases in unbound diazepam and warfarin, respectively, show low affinity and a high degree of binding-site saturation in the analbuminemic plasma. The proportion of unbound drug will therefore be very dependent on total drug concentration. Fluctuations of the free drug concentration over a dosing interval will be greater, which in turn will result in a more rapid onset of drug action, a greater peak response, and the earlier appearance of toxicity (30) . These effects may be even more exaggerated for albu-mm-bound drugs such as salicylates, which, in usual doses, are present at much higher drug/albumin ratios than either diazepam or warfarin. (22) found that the concentration of a1-acid glycoprotein ranged from 2240 down to 530 mg/L as unbound propranolol increased from 5.0 to 11.8% of total drug. The lower concentrations of free drug in this child, therefore, cannot be accounted for solely by high a1-acid glycoprotein concentrations, but may be due to concomitant increases in LDL and HDL.
